Keyword: Drug plan management

452 results found

A British Columbia labour arbitration decision is providing insight on how a block level implementation of a benefits provider’s drug cost-control program violated a collective agreement in a unionized workplace. The Douglas College Faculty Association grieved the implementation of Manulife’s DrugWatch program contravened their collective agreement, which ensured “there will be no change to the […]

The coronavirus pandemic has marked a sea change in how Canadians receive health care. While just four per cent of primary care visits were conducted virtually pre-pandemic, that rose to roughly 60 per cent after the onset of the global health crisis. This represents an opportunity to reshape how health care can be delivered and, in […]

A typical patient’s journey takes plan members from the doctor to the pharmacy for medication and then leaves them on their own. But employees’ lives aren’t static, with factors like age, mental and physical health, stress and activity level having the potential to impact how effectively those medications work, said Frederic Simard, co-founder and chief […]

Does your organization’s benefits plan or financial wellness program deserve recognition? Are you leading the way when it comes to supporting your employees’ mental health? Is your company implementing award-worthy diversity, equity and inclusion initiatives? Benefits Canada’s annual Workplace Benefits Awards is officially open for nominations. Submit your entries here. As in previous years, the 2022 awards will […]

  • By: Staff
  • April 29, 2022 April 29, 2022
  • 09:05

After multiple delays, the amendments to the Patented Medicines Review Board regulations will finally come into force on July 1, 2022. Last week, Health Minister Jean-Yves Duclos announced the federal government will proceed with the amendments to provide the PMPRB with new tools to protect Canadians from excessive prices for patented medicines. “This will improve access for […]

  • By: Staff
  • April 19, 2022 April 18, 2022
  • 09:00

Amid plans by the federal government to introduce national dental and pharmacare programs, key stakeholders in the private payer health-care sector should highlight the value of private health plans in Canada, according to a panel during a webinar by the Group Insurance Pharmaceutical Committee last week. In March, the Liberal Party and the New Democratic […]

Copyright_Wavebreak Media Ltd_123RF

Changes to Quebec’s policy on the use of biosimilars in its public drug plan could result in savings for private benefits plans, says one expert. On April 13, 2022, the Régie de l’assurance maladie du Québec will delist certain biologic drugs from its formulary, requiring patients covered by the plan to switch to a biosimilar […]

While the overall private drug plan spend per member increased by 4.3 per cent in 2021, fewer plan members submitted claims and the per-claimant cost grew, according to Express Scripts Canada’s latest prescription drug trends report. Specifically, the percentage of plan members that made a claim decreased by 0.3 per cent last year while spend […]

  • By: Staff
  • April 6, 2022 April 6, 2022
  • 09:00

A migraine attack is much more severe than a headache because it comes with a lot of other symptoms, according to Dr. Elizabeth Leroux, a neurologist, president of the Canadian Headache Society and chair of Migraine Canada, speaking during a session supported by Abbvie at Benefits Canada‘s Chronic Disease at Work event in February. Migraine, […]

Lupus, a chronic but “invisible” autoimmune disease with no cure, is a life-altering diagnosis that impacts all areas of patients’ lives, including their work performance. But there’s plenty employers can do to support these employees and help them continue to thrive at work, said Leanne Mielczarek, executive director of Lupus Canada, during Benefits Canada’s 2022 […]